参考文献
-
1) Subchronic Exposure to Polystyrene Nanoplastics Disrupts Placental Development and Calcium Homeostasis: Insights from In Vivo and In Vitro Models.
-
2) Unlocking Neuroprotection: Simultaneous Suppression of Mitochondrial Energetic Collapse and Oxidative-Inflammatory Vortex for Ischemia-Reperfusion Brain Injury.
-
3) An Antigen-Free Nanovaccine-Enabled Holo-Immunotherapy for Establishing Robust Memory Immune Tolerance in Autoimmune Diseases.
-
4) Low miR-224-5p in exosomes confers colorectal cancer 5-FU resistance by upregulating S100A4.
-
5) Oligodendroglial precursor cells modulate immune response and early demyelination in a murine model of multiple sclerosis.
-
6) Deep Learning Enhanced Near Infrared-II Imaging and Image-Guided Small Interfering Ribonucleic Acid Therapy of Ischemic Stroke.
-
7) Nanosized Shikonin Disrupts Tumor-cell Mismatch Repair and Synergizes with Manganese to Sensitize Squamous Carcinoma to Immunotherapy.
-
8) A Noninvasive Nanoeyedrop Therapy for the Inhibition of Uveal Melanoma: Tetrahedral Framework Nucleic Acid-Based Bioswitchable MicroRNA Delivery System.
-
9) Antibacterial Peptides-Produced Cell Hydrogel Eliminates Intracellular Pathogens and Remodels Immune Microenvironment for Osteomyelitis Therapy.
-
10) Cascade-Type Microglial Pyroptosis Inhibitors for Enhanced Treatment of Cerebral Ischemia-Reperfusion Injury.
-
11) Multifunctional Nanomedicine for Targeted Atherosclerosis Therapy: Activating Plaque Clearance Cascade and Suppressing Inflammation.
-
12) UCP2 inhibition eliminates pancreatic β cell autoinflammation in type 2 diabetes mellitus with Islet-mitochondrial sequential targeting nanomedicines..
-
13) An eNOS-like nanomaterial for specific reversal of cerebral ischemia-reperfusion injury.
-
14) Phenazine biosynthesis-like domain containing protein (PBLD) and Cedrelone promote antiviral immune response by activating NF-ĸB.
製品: 1Year: 2025ジャーナル: NAT COMMUNImpactFactor: 15.700DOI: https://www.nature.com/articles/s41467-024-54882-y -
15) Mitoxantrone-Encapsulated ZIF-8 Enhances Chemo-Immunotherapy via Amplified Immunogenic Cell Death.